Health Insurance (Section 3C General Medical Services – Telehealth and Telephone Attendances) Amendment (COVID-19 Positive Patients Exemption) Determination 2022
I, Nigel Murray, delegate of the Minister for Health and Aged Care, make the following Determination.
Dated 17 October 2022
Nigel Murray
Assistant Secretary
Medical Benefits Division
Health Resourcing Group
Department of Health and Aged Care
Contents
2 Commencement
3 Authority
4 Schedules
Schedule 1— Amendments
Health Insurance (Section 3C General Medical Services – Telehealth and Telephone Attendances) Determination 2021
This instrument is the Health Insurance (Section 3C General Medical Services – Telehealth and Telephone Attendances) Amendment (COVID-19 Positive Patients Exemption) Determination 2022.
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information | ||
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | 13 October 2022. |
|
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
This instrument is made under subsection 3C(1) of the Health Insurance Act 1973.
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
1 Subsection 5(1)
Insert:
person who has tested positive for COVID-19 means a patient who has received a positive COVID-19 test result within the last 7 days, confirmed by either:
(a) Laboratory testing (PCR); or
(b) A COVID-19 rapid antigen self test (RAT) which has been approved for supply in Australia by the Therapeutic Goods Administration.
2 After subparagraph 7(6)(a)(vi)
Insert:
(vii) a person who has tested positive for COVID-19; or